Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients

Nishi N Shah, MBBS, Ajay K. Nooka, MD, MPH, Jonathan L. Kaufman, MD, Daniela Casbourne, FNP-BC, AOCNP, Donald Hutcherson, Rachael Maynard, MPH, Edmund K. Waller, MD, PhD, Sagar Lonial, M.D., Amelia Langston, MD

Blood (2013) 122 (21): 2986.

https://doi.org/10.1182/blood.V122.21.2986.2986

Published: 2013

Journal Articles

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Rajni Sinha, MD, MRCP, Nassoma King, PA, Pareen J Shenoy, MBBS, MPH, Mary Jo Lechowicz, MD, Kevin Bumpers, MHA, Donald Hutcherson, Martha Arellano, MD, Amelia Langston, MD, Jonathan L. Kaufman, MD, Leonard T. Heffner, MD, Edmund K Waller, MD PhD, Christopher R Flowers, MD, Sagar Lonial, MD

Blood (2011) 118 (21): 1628.

https://doi.org/10.1182/blood.V118.21.1628.1628

Published: 2011

Journal Articles

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Hongzheng Zhang, Michael Graiser, Donald Hutcherson, M. Olufemi Dada, Stephanie McMillan, BSN, RN, OCN, Ali Zahir, Christopher R Flowers, MD, MS, Edmund Waller

Blood (2010) 116 (21): 1359.

https://doi.org/10.1182/blood.V116.21.1359.1359

Published: 2010

Journal Articles

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Amelia A. Langston, MD, Leonard T. Heffner, MD, Donald Hutcherson, RPh, Jessica Neely, MS, Christopher Flowers, MD, MS, Edmund K. Waller, MD, PhD, Sagar Lonial, MD, Hanna J. Khoury, MD, Elliot Winton, MD

Blood (2005) 106 (11): 4634.

https://doi.org/10.1182/blood.V106.11.4634.4634

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Email alerts

ASH Publications

American Society of Hematology

Update search

Evaluating Risk Factors and Outcomes For Clostridium Difficile Infection (CDI) In Stem Cell Transplant (SCT) Recipients

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Pharmocokinetic (PK)-Directed High Dose Intravenous Busulfan, Cyclophosphamide and Etoposide Produces Predictable Drug Exposure and Durable Long Term Survival In Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only